These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14673046)

  • 1. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
    Skotheim RI; Kallioniemi A; Bjerkhagen B; Mertens F; Brekke HR; Monni O; Mousses S; Mandahl N; Soeter G; Nesland JM; Smeland S; Kallioniemi OP; Lothe RA
    J Clin Oncol; 2003 Dec; 21(24):4586-91. PubMed ID: 14673046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours.
    Storlazzi CT; Brekke HR; Mandahl N; Brosjö O; Smeland S; Lothe RA; Mertens F
    J Pathol; 2006 Aug; 209(4):492-500. PubMed ID: 16721726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group.
    Brekke HR; Ribeiro FR; Kolberg M; Agesen TH; Lind GE; Eknaes M; Hall KS; Bjerkehagen B; van den Berg E; Teixeira MR; Mandahl N; Smeland S; Mertens F; Skotheim RI; Lothe RA
    J Clin Oncol; 2010 Mar; 28(9):1573-82. PubMed ID: 20159821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.
    Mueller RE; Parkes RK; Andrulis I; O'Malley FP
    Genes Chromosomes Cancer; 2004 Apr; 39(4):288-97. PubMed ID: 14978790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
    Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
    Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
    Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
    Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
    Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
    Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
    Amirnasr A; Verdijk RM; van Kuijk PF; Taal W; Sleijfer S; Wiemer EAC
    PLoS One; 2017; 12(8):e0183155. PubMed ID: 28813519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
    Kresse SH; Skårn M; Ohnstad HO; Namløs HM; Bjerkehagen B; Myklebost O; Meza-Zepeda LA
    Mol Cancer; 2008 Jun; 7():48. PubMed ID: 18522746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
    da Cunha IW; De Brot L; Carvalho KC; Rocha RM; Fregnani JH; Falzoni R; Ferreira Fde O; Aguiar S; Lopes A; Muto NH; Reis LF; Soares FA; Vassallo J
    Ann Surg Oncol; 2012 Jun; 19(6):1790-9. PubMed ID: 22203181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway.
    Berner JM; Sørlie T; Mertens F; Henriksen J; Saeter G; Mandahl N; Brøgger A; Myklebost O; Lothe RA
    Genes Chromosomes Cancer; 1999 Oct; 26(2):151-60. PubMed ID: 10469453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
    Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
    Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array.
    Mantripragada KK; Díaz de Ståhl T; Patridge C; Menzel U; Andersson R; Chuzhanova N; Kluwe L; Guha A; Mautner V; Dumanski JP; Upadhyaya M
    Genes Chromosomes Cancer; 2009 Oct; 48(10):897-907. PubMed ID: 19603524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
    Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
    Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study.
    Hicks DG; Yoder BJ; Pettay J; Swain E; Tarr S; Hartke M; Skacel M; Crowe JP; Budd GT; Tubbs RR
    Hum Pathol; 2005 Apr; 36(4):348-56. PubMed ID: 15891995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization.
    Mechtersheimer G; Otaño-Joos M; Ohl S; Benner A; Lehnert T; Willeke F; Möller P; Otto HF; Lichter P; Joos S
    Genes Chromosomes Cancer; 1999 Aug; 25(4):362-9. PubMed ID: 10398430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.